DUBLIN--(BUSINESS WIRE)--The "Global Emergency Contraceptive Pill Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The Global Emergency Contraceptive Pill Market is expected to grow at a CAGR of 2.55% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend affecting this market is the advent of online apps The widespread use of emergency contraceptive pills worldwide, has led to the emergence of apps such as Lemonaid, Nurx, and Virtuwell that allow users to select the type and brand of emergency contraceptive pills by giving a variety of options.
According to the report, one driver influencing this market is the rise in the number of initiatives to create awareness. With the rise in the number of unplanned pregnancies worldwide, several governments and academic institutes are stepping in to promote the usage of contraception, including emergency contraceptive pills.
Further, the report states that one challenge affecting this market is the local governments limiting access to emergency contraceptive pills. Since the approval of the Plan B One-Step contraceptive pill by the FDA in 2013, that can be acquired without prescription or age restrictions, the use of the product has increased among teenagers. However, the distribution of such products is restricted on moral or ethical grounds.
- Mankind Pharma
- Piramal Enterprises
- Sun Pharmaceutical Industries
Key Topics Covered
01. Executive Summary
02. Scope of the Report
03. Research Methodology
04. Market Landscape
05. Market Sizing
06. Five Forces Analysis
07. Market Segmentation by Distribution Channel
08. Customer Landscape
09. Regional Landscape
10. Decision Framework
11. Drivers and Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/xlmx39/global_emergency?w=4